Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Operating Leases (2021 - 2023)

Dna X (SONM) has disclosed Operating Leases for 3 consecutive years, with $55000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Operating Leases fell 16.67% year-over-year to $55000.0, compared with a TTM value of $55000.0 through Dec 2023, down 16.67%, and an annual FY2023 reading of $55000.0, down 16.67% over the prior year.
  • Operating Leases was $55000.0 for Q4 2023 at Dna X, down from $120000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.8 million in Q1 2022 and bottomed at $55000.0 in Q4 2023.
  • Average Operating Leases over 3 years is $360714.3, with a median of $120000.0 recorded in 2023.
  • The sharpest move saw Operating Leases changed 0.0% in 2022, then plummeted 85.48% in 2023.
  • Year by year, Operating Leases stood at $66000.0 in 2021, then changed by 0.0% to $66000.0 in 2022, then decreased by 16.67% to $55000.0 in 2023.
  • Business Quant data shows Operating Leases for SONM at $55000.0 in Q4 2023, $120000.0 in Q3 2023, and $183000.0 in Q2 2023.